Suryaningtyas Indyaswan T, Jung Won-Kyo, Je Jae-Young
Research Center for Marine-Integrated Bionics Technology, Pukyong National University, Busan, Republic of Korea.
Research Center for Food Technology and Processing, National Research and Innovation Agency (BRIN), Yogyakarta, Indonesia.
Biofactors. 2025 Jul-Aug;51(4):e70035. doi: 10.1002/biof.70035.
Browning of white adipose tissue offers a promising strategy to manage obesity by enhancing thermogenesis and lipid oxidation. Although fucosterol, a phytosterol found in brown seaweeds, has been recognized for its antioxidant and metabolic benefits, its ability to trigger browning has not been previously reported. In this study, we demonstrate for the first time that fucosterol induces adipocyte browning in 3T3-L1 cells. Treatment with fucosterol (10-50 μM) during adipogenic differentiation suppressed lipid accumulation and downregulated adipogenic transcription factors (PPARγ, C/EBPα, SREBP-1), while enhancing lipolysis via increased phosphorylation of HSL and AMPK. Critically, browning markers PRDM16, PGC1α, and UCP1 were robustly upregulated in a dose-dependent manner. Fucosterol also activated the Nrf2/HO-1 antioxidant pathway, as evidenced by increased HO-1 expression and Nrf2 nuclear translocation. Pharmacological inhibition of HO-1 or AMPK reversed these effects, confirming their essential role in fucosterol-induced thermogenic remodeling. Interestingly, despite activation of p38 and ERK MAPKs-often linked to stress signaling-fucosterol reduced pro-inflammatory cytokine levels (IL-6, IL-1β, TNF-α) and elevated antioxidant enzymes (SOD, GPx, CAT), suggesting a non-inflammatory metabolic adaptation. These findings reveal a previously uncharacterized function of fucosterol in promoting adipocyte browning, driven by HO-1/Nrf2 and AMPK pathways, with potential relevance for therapeutic strategies targeting obesity.
白色脂肪组织的褐变提供了一种通过增强产热和脂质氧化来控制肥胖的有前景的策略。尽管岩藻甾醇(一种在褐藻中发现的植物甾醇)因其抗氧化和代谢益处而得到认可,但其引发褐变的能力此前尚未见报道。在本研究中,我们首次证明岩藻甾醇可诱导3T3-L1细胞中的脂肪细胞褐变。在脂肪生成分化过程中用岩藻甾醇(10 - 50 μM)处理可抑制脂质积累并下调脂肪生成转录因子(PPARγ、C/EBPα、SREBP-1),同时通过增加激素敏感脂肪酶(HSL)和腺苷酸活化蛋白激酶(AMPK)的磷酸化来增强脂肪分解。至关重要的是,褐变标志物PRDM16、PGC1α和UCP1以剂量依赖性方式强烈上调。岩藻甾醇还激活了Nrf2/HO-1抗氧化途径,HO-1表达增加和Nrf2核转位证明了这一点。HO-1或AMPK的药理学抑制逆转了这些作用,证实了它们在岩藻甾醇诱导的产热重塑中的重要作用。有趣的是,尽管p38和ERK丝裂原活化蛋白激酶(MAPKs)的激活通常与应激信号传导有关,但岩藻甾醇降低了促炎细胞因子水平(IL-6、IL-1β、TNF-α)并提高了抗氧化酶(超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)、过氧化氢酶(CAT)),表明存在非炎症性代谢适应。这些发现揭示了岩藻甾醇在促进脂肪细胞褐变方面以前未被表征的功能,由HO-1/Nrf2和AMPK途径驱动,对针对肥胖的治疗策略具有潜在相关性。